Netherlands· NL-78564b1ec5f7
Akynzeo 235 mg / 0.25 mg concentraat voor oplossing voor infusie
A palonosetron, kombinationen product containing fosnetupitantchloridehydrochloride + palonosetronhydrochloride, registered in Netherlands by Helsinn Birex Pharmaceuticals Limited. The same ATC class is registered in 11 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Palonosetron, kombinationen is registered in 11 of 19 countries.
Countries holding a registration under ATC A04AA55 (palonosetron, kombinationen), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 7 of them publish a price we can compare per daily dose
Palonosetron, kombinationen · ATC A04AA55
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
Price per daily dose
What a daily dose of palonosetron, kombinationen costs, country by country.
Normalised to the WHO defined daily dose (0.5 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Palonosetron, kombinationen · price per daily dose (0.5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.20
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- FOSNETUPITANTCHLORIDEHYDROCHLORIDE + PALONOSETRONHYDROCHLORIDE
- Manufacturer
- Helsinn Birex Pharmaceuticals Limited
- Country
- Netherlands (NL)
- ATC code
- A04AA55
- ATC class
- Palonosetron, Kombinationen
- Defined daily dose
- 0.5 mg, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/15/1001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Palonosetron, kombinationen in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesAKYNZEOHelsinn Therapeutics (U.S.), Inc.
- SwitzerlandAkynzeo IV
- SpainAKYNZEO 235 MG/0,25 MG POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓNHelsinn Birex Pharmaceuticals Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Akynzeo
- Liechtenstein · Akynzeo
- Norway · Akynzeo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2bd0e7ad-283c-4ebe-9ca6-7c922d801e1b GET /v1/drugs/2bd0e7ad-283c-4ebe-9ca6-7c922d801e1b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Concentraat voor oplossing voor infusie",
"route": "Intraveneus gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/akynzeo-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Palonosetron, combinations",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp127356",
"excipients": [
"DINATRIUMEDETAAT 2-WATER",
"MANNITOL (D-) (E 421)",
"NATRIUMHYDROXIDE (E 524)",
"WATER VOOR INJECTIE",
"ZOUTZUUR (E 507)"
],
"substances": [
"FOSNETUPITANTCHLORIDEHYDROCHLORIDE",
"PALONOSETRONHYDROCHLORIDE"
],
"leaflet_url": null,
"authorised_at": "2021/11/12",
"procedure_number": "EMEA/H/C/003728",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/15/1001",
"additional_monitoring": "N"
}See everything about palonosetron, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.